e-poster

	Click the title to download the ppt or pptx e-Poster
P01	THE HISTORY OF EVIDENCE-BASED HEALTHCARE: THE ASCENT OF BEDSIDE MEDICINE
P02	THE WARDS ARE GREENER THEREFORE MORE THERAPEUTIC - DO THE PATIENTS KNOW ABOUT IT
P03	EXPLORING THE ROLE OF GENETIC COUNSELING IN NEURODEGENERATIVE DISORDERS
P04	COMPULSIVE SEXUAL BEHAVIOUR DISORDER AND SEXUAL MOTIVATIONS
P05	ASSOCIATION OF VALPROIC ACID TREATMENT WITH 25-OH VITAMIN D LEVELS IN HOSPITALIZED PSYCHIATRIC PATIENTS
P06	IS THERE A LONG-TERM IMPACT OF RESILIENCE-BUILDING INTERVENTIONS IN NURSES? A SCOPING REVIEW
P07	LIGHT AND FOOD: BODY IMAGE MODERATES THE EFFECTS OF CHRONOTYPE ON THE RISK TO DEVELOP EATING DISORDERS
P08	THE GREEK VERSION OF THE QUICK APHASIA BATTERY (QAB): PRELIMINARY VALIDATION DATA ON ASSESSING MONOLINGUAL TYPICAL ADULTS
P09	THE GREEK VERSION OF THE APHASIA RAPID TEST (ART) PRELIMINARY VALIDATION DATA ON ASSESSING MONOLINGUAL TYPICAL ADULTS
P10	THE GREEK VERSIONS OF THE APHASIA RAPID TEST (ART) AND THE QUICK APHASIA BATTERY (QAB): A PILOT VALIDATION STUDY WITH TYPICAL BILINGUAL GREEK SPEAKING ADULTS
P11	AUTISM SPECTRUM QUOTIENT-ADOLESCENT (ASQ-A) AND THE AUTISM SPECTRUM SCREENING QUESTIONNAIRE (ASQ) IN GREEK: A PRELIMINARY VALIDATION STUDY
P13	EFFECTIVENESS OF CARIPRAZINE AS ADJUNCTIVE TREATMENT IN A COMPLEX FORENSIC PSYCHIATRY CASE: A CASE REPORT
P14	EFFECTIVENESS OF LURASIDONE AS ADJUNCTIVE TREATMENT IN A CASE OF SCHIZOPHRENIA: A FORENSIC PSYCHIATRY CASE REPORT
P15	NAVIGATING TREATMENT FRONTIERS: OPTIMIZING SCHIZOPHRENIA TREATMENT THROUGH A HERETICAL CLOZAPINE CESSATION - A FORENSIC PSYCHIATRY CASE STUDY
P16	EVALUATION OF BRAIN REGIONAL NEUROGENESIS IN A PHARMACOLOGICAL ZEBRAFISH MODEL OF SOCIAL DEFICITS
P17	THE PRICE OF SAFETY: EVALUATING THE COST OF CONTAINMENT INTERVENTIONS IN PSYCHIATRIC CARE - A COMPREHENSIVE LITERATURE REVIEW WITH INSIGHTS FROM HELLENIC PSYCHIATRIC HEALTHCARE FACILITIES
P18	EXAMINING THE POSSIBLE CORRELATION AMONG PERSONALITY DYSFUNCTION, PATHOLOGICAL TRAITS, AND INTERNALIZED STIGMA IN INDIVIDUALS DIAGNOSED WITH PERSONALITY DISORDERS
P19	THE ROLE OF BIOMARKERS IN THE TREATMENT RESPONSE TO CLOZAPINE AND RISPERIDONE IN SCHIZOPHRENIA
P20	THE IMPACT OF POST-COVID-19 SYNDROME ON COGNITIVE FUNCTIONS: A SYSTEMATIC REVIEW
P21	UNDERSTANDING STIGMA ASSOCIATED WITH PERSONALITY DISORDERS TO IMPROVE WELL-BEING OF PATIENTS
P22	PROSOCIAL MORAL REASONING, EMPATHY AND PROSOCIAL BEHAVIOR IN EMERGING ADULTS
P23	ATTENTION DEFICIT AND HYPERACTIVITY DISORDER, IN ADULTS
P24	DEMOGRAPHIC FEATURES OF VIOLENT AND NON-VIOLENT SUICIDE SAMPLES AMONG TREATED INPATIENTS BETWEEN 2016-2021 IN BUDAPEST, HUNGARY

e-Posters

Congress Secretariat